Tempest Therapeutics Inc (NASDAQ:TPST) shares, rose in value, with the stock price down by -12.95% to the previous day’s close as strong demand from buyers drove the stock to $0.96.
Actively observing the price movement in the last trading, the stock closed the session at $1.10, falling within a range of $0.88 and $1.045. The value of beta (5-year monthly) was -2.899. Referring to stock’s 52-week performance, its high was $6.00, and the low was $0.92. On the whole, TPST has fluctuated by -28.00% over the past month.
With the market capitalization of Tempest Therapeutics Inc currently standing at about $24.14 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2024-Nov-06.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TPST’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of TPST currently trading nearly -17.24% and -24.58% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 33.68, while the 7-day volatility ratio is showing 10.14% which for the 30-day chart, stands at 13.61%. Furthermore, Tempest Therapeutics Inc (TPST)’s beta value is -1.83, and its average true range (ATR) is 0.13.
A comparison of Tempest Therapeutics Inc (TPST) with its peers suggests the former has fared considerably weaker in the market. TPST showed an intraday change of -12.95% in last session, and over the past year, it shrunk by -75.32%%.
Data on historical trading for Tempest Therapeutics Inc (NASDAQ:TPST) indicates that the trading volumes over the past 10 days have averaged 5.05 and over the past 3 months, they’ve averaged 4.51 million. According to company’s latest data on outstanding shares, there are 22.05 million shares outstanding.
Nearly 15.95% of Tempest Therapeutics Inc’s shares belong to company insiders and institutional investors own 7.10% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.72 million shares as on 2024-10-15, resulting in a short ratio of 1.03. According to the data, the short interest in Tempest Therapeutics Inc (TPST) stood at 1780.00 of shares outstanding as of 2024-10-15; the number of short shares registered in 2024-09-13 reached 1.92 million. The stock has fallen by -78.24% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TPST stock heading into the next quarter.
